Trials / Completed
CompletedNCT00765310
Lipoic Acid and Prevention of Heart Disease
The Role of R-alpha Lipoic Acid in Prevention of Atherosclerotic Vascular Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Oregon State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors such as body weight and high blood cholesterol levels in overweight or obese participants.
Detailed description
The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors such as body weight and high blood cholesterol levels in overweight or obese participants. Recruitment will be in the Portland, Oregon area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | R-alpha lipoic acid | 600 mg in morning on empty stomach (two 300 mg capsules) |
| DIETARY_SUPPLEMENT | Placebo | two capsules once daily in morning on empty stomach |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-11-01
- Completion
- 2024-10-01
- First posted
- 2008-10-02
- Last updated
- 2025-04-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00765310. Inclusion in this directory is not an endorsement.